BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10492251)

  • 1. Activation of extracellular signal-regulated kinase in human prostate cancer.
    Price DT; Della Rocca G; Guo C; Ballo MS; Schwinn DA; Luttrell LM
    J Urol; 1999 Oct; 162(4):1537-42. PubMed ID: 10492251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
    Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
    Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role for G proteins in prostate cancer cell growth and signaling.
    Kue PF; Daaka Y
    J Urol; 2000 Dec; 164(6):2162-7. PubMed ID: 11061948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer.
    Yeh AH; Jeffery PL; Duncan RP; Herington AC; Chopin LK
    Clin Cancer Res; 2005 Dec; 11(23):8295-303. PubMed ID: 16322288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2.
    Xiao D; Choi S; Johnson DE; Vogel VG; Johnson CS; Trump DL; Lee YJ; Singh SV
    Oncogene; 2004 Jul; 23(33):5594-606. PubMed ID: 15184882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of the 41- and 43-kDa mitogen-activated protein (MAP) kinases in the progression of prostate cancer to an androgen-independent state.
    Oka H; Chatani Y; Kohno M; Kawakita M; Ogawa O
    Int J Urol; 2005 Oct; 12(10):899-905. PubMed ID: 16323984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).
    Aguirre-Ghiso JA; Estrada Y; Liu D; Ossowski L
    Cancer Res; 2003 Apr; 63(7):1684-95. PubMed ID: 12670923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular signal-regulated kinase 1/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein 1 and nuclear factor kappaB transcription factors play central roles in interleukin-8 expression stimulated by monosodium urate monohydrate and calcium pyrophosphate crystals in monocytic cells.
    Liu R; O'Connell M; Johnson K; Pritzker K; Mackman N; Terkeltaub R
    Arthritis Rheum; 2000 May; 43(5):1145-55. PubMed ID: 10817569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer.
    Uzgare AR; Kaplan PJ; Greenberg NM
    Prostate; 2003 May; 55(2):128-39. PubMed ID: 12661038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
    Jiménez E; Montiel M
    J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells.
    Vintman L; Nielsen S; Berner A; Reich R; Davidson B
    Cancer; 2005 Jun; 103(11):2427-33. PubMed ID: 15830375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
    Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leuprorelin acetate affects ERK1/2 activity in prostate cancer cells.
    Iacopino F; Lama G; Angelucci C; Sica G
    Int J Oncol; 2006 Jul; 29(1):237-47. PubMed ID: 16773205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective reduction of extracellular signal-regulated protein kinase (ERK) phosphorylation in squamous cell carcinoma of the larynx.
    Garavello W; Nicolini G; Aguzzi A; Maggioni D; Leone BE; Viganò P; Gaini RM; Tredici G
    Oncol Rep; 2006 Sep; 16(3):479-84. PubMed ID: 16865246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
    Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
    J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of mitogen-activated protein kinase cascades by differentiation-1 protein: acquired drug resistance of hormone independent prostate cancer cells.
    Lin JC; Chang SY; Hsieh DS; Lee CF; Yu DS
    J Urol; 2005 Nov; 174(5):2022-6. PubMed ID: 16217386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.